OOIR: Observatory of International Research

Papers

(The median citation count of Pediatric Blood & Cancer is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
	83
	49
	42
	42
Feasibility of indocyanine green‐guided localization of pulmonary nodules in children with solid tumors	39
Children's Oncology Group 2023 blueprint for research: Cancer care delivery research	38
The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta‐analysis	38
Psychosexual functioning in cancer survivorship: What the pediatric oncologist needs to know	36
Efficacy of dual‐task training on stability and function in children with ataxia after medulloblastoma resection: A randomized controlled trial	35
After 75 Years of Methotrexate, Can Treatment Results Be Improved With Appropriate Folinic Acid Rescue?	33
Image‐Guided Biopsy for the Diagnosis and Molecular Profiling of Hepatoblastoma	33
Bloodletting as Medical Child Abuse Revealed by Lack of Iron Accumulation Despite Multiple Erythrocyte Transfusions	28
Impact of Food Insecurity on Malnutrition Treatment Response in Nigerian Children With Sickle Cell Anemia and Severe Acute Malnutrition	27
The Ukrainian children emergency: How the Pediatric Oncology Unit of Turin supports cancer patients and their families who have escaped war	26
Global nLPHL One Working Group (GLOW) Research Roadmap for Nodular Lymphocyte‐Predominant Hodgkin Lymphoma	26
Fatal brainstem injury following proton radiation in a patient with medulloblastoma and a germline variant in RNF213	25
Strategies for the Treatment of Desmoplastic Small Round Cell Tumor: A Case Series	25
Bone mineral density in primarily preadolescent children with hemoglobin E/β‐thalassemia with different severities and transfusion requirements	25
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors	25
Recombinant von Willebrand factor for perioperative bleeding management in pediatric patient with allergy to plasma‐derived von Willebrand factor	24
Mini‐hyper CVD + CRIB (condensed rituximab, inotuzumab ozogamicin, and blinatumomab) for refractory pediatric B‐acute lymphoblastic leukemia	24
Late mortality reduction among survivors of germ cell tumors in childhood and adolescence in Europe: A report from the PanCareSurFup cohort	23
Metastatic and multiply relapsed SDH‐deficient GIST and paraganglioma displays clinical response to combined poly ADP‐ribose polymerase inhibition and temozolomide	23
Feasibility of treating pediatric intracranial germ cell tumors in a middle‐income country: The Jordanian experience	23
How we approach complex vascular anomalies and overgrowth syndromes	22

Lactate dehydrogenase reflects the status of ultra‐high‐risk neuroblastoma in a child under treatment	21
Glomerular filtration rate in children and young adults with haemato‐oncological disease and infection is best described by three‐compartment iohexol model	21
Neonatal giant axillary hemangioma with subclavian arteriovenous fistula and heart failure	21
Platelet changes and bleeding symptoms in children, adolescents, and adults with 22q11.2 deletion syndrome	21
Central nervous system thrombosis in pediatric acute lymphoblastic leukemia in Turkey: A multicenter study	21
Prognostic factors of sepsis in children with acute leukemia admitted to the pediatric intensive care unit	21
ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant	20
Refractory thrombocytopenia and myelofibrosis in a novel KDSR mutation: Case report and literature review	20
Quality of life and late therapy effects in pediatric non‐Hodgkin lymphoma survivors: Insights from a single‐institution study	20
Pediatric erythroblastic transformation of JAK2‐mutated prefibrotic primary myelofibrosis with concurrent PHF6 mutations	20
Ultrastructural investigation on pseudo Chediak–Higashi abnormality in acute lymphoblastic leukemia: A case report	20
Response assessment by positron emission tomography‐computed tomography as compared with contrast‐enhanced computed tomography in childhood Hodgkin lymphoma can reduce the need for radiotherapy in low	20
A community‐based trial of a psychosocial eHealth intervention for parents of children with cancer	19
Cabozantinib in children with recurrent diffuse gliomas	19
Luspatercept for non‐deletional hemoglobin H disease	19
Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes	19
Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy	18
High‐dose carboplatin–irinotecan–temozolomide is an effective salvage chemotherapy for relapsed or refractory neuroblastoma	18
A three‐year‐old with central nervous system graft versus host disease: A rare cause of posthematopoietic stem cell transplant encephalopathy	18
Outcomes of Wilms tumor therapy in Lilongwe, Malawi, 2016–2021: Successes and ongoing research priorities	18
KMT2A‐MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8‐year follow‐up	18
Kaposiform hemangioendothelioma of the bone in children and adolescents	18
Late‐onset lymphopenia during radiation is associated with an increased risk of tumor recurrence in newly diagnosed pediatric medulloblastoma	18
Incidence and 5‐year survival of children and adolescents with hepatoblastoma in the United States	17
	17
Prevalence of Duffy null and its impact on hydroxyurea in young children with sickle cell disease in the United States	17
Choriocarcinoma in neonates and infants: A severe but curable disease	17
Palliative care and suicidality: Complicated conversations at two ends of the spectrum	17
Implementation of physical rehabilitation programs for children with cancer across low‐ and middle‐income countries: A need of the hour perspective	17
Brochure intervention to manage bothersome taste changes in pediatric patients receiving cancer therapy	17
Social determinants of neurocognitive and academic performance in sickle cell disease	16
Shwachman–Diamond Syndrome Patient Progressing From Chronic Myelomonocytic Leukemia to Acute Myeloid Leukemia Within Two Months	16
A randomized double‐blind placebo‐controlled trial of the effectiveness of melatonin on neurocognition and sleep in survivors of childhood cancer	16
Benchmarks for Psychosocial Staffing in Pediatric Oncology: Implementing the Standards Together—Engaging Parents and Providers in Psychosocial Care (iSTEPPP) Study	16
Comparing Absolute Neutrophil Counts of Children With Sickle Cell Disease With and Without the Duffy Null Phenotype	16
New Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor Committee	16
Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Reg	15
How we approach coagulopathy with vascular anomalies	15
No wrong decisions in an all‐wrong situation. A qualitative study on the lived experiences of families of children with diffuse intrinsic pontine glioma	15
	15
Automating the treatment planning process for 3D‐conformal pediatric craniospinal irradiation therapy	15
Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity	14
Inclusion of Optic Pathway and Hypothalamic Tumors in Prognostic Studies of Pilocytic Astrocytoma: Is It Justified?	14
Desensitization with daratumumab in a pediatric patient with thalassemia major and high donor‐specific antibody prior to haploidentical transplantation	14
Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder	14
Ring sideroblasts and macrocytic anemia in an infant: Clues to the diagnosis of Pearson syndrome	14
Prognostic value of texture analysis of the primary tumour in high‐risk neuroblastoma: An ¹⁸F‐DOPA PET study	14
Refractory, fatal autoimmune hemolytic anemia due to ineffective thymic‐derived T‐cell reconstitution following allogeneic hematopoietic cell transplantation for hypomorphic RAG1 deficiency	14
Diminished ovarian reserve in adolescent cancer survivors treated with heavy metal chemotherapy	14
Clinical characteristics and outcomes of SARS‐CoV‐2 infection in pediatric oncology patients in the province of Quebec	14

Comment on: Incorporation of patient‐reported outcomes in early‐phase clinical trials for childhood and adolescent cancer	14
Case report: Dichloroacetate‐induced methaemoglobinaemia in a G6PD‐deficient neonate	14
Implementation science in pediatric oncology: A narrative review and future directions	14
	14
Wiskott–Aldrich syndrome protein expression in female WAS carriers: A flow cytometry study from North India	14
Mesial temporal pilocytic astrocytoma compressing brainstem: Clinical cure after stereotactically inserted Ommaya and radiosurgery‐induced shrinkage	14
Issue Information	14
Resource‐appropriate selection of osteosarcoma treatment protocols in low‐ and middle‐income countries	14
First‐Line Postremission Blinatumomab as Successful Toxicity‐Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic Leukemia	14
Survival of pediatric patients requiring admission in the intensive care unit post hematopoietic stem cell transplantation: Prognostic factors associated with mortality	13
Successful Erwinia asparaginase one‐bag rapid desensitization process in a pediatric patient with acute lymphoblastic leukemia	13
The Role of Perceived Health‐Related Information Adequacy in the Experiences of Parents of Children With Complex Vascular Anomalies	13
Pediatric Mixed Phenotype Acute Leukemia With ETV6::ARNT Fusion Gene Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation	13
Concurrent carcinocythemia, chest wall and right knee joint involvement in Ewing sarcoma	13
Posterior Mediastinal Tumor Presenting with Compressive Myelopathy: Uncommon Site for a Rare Tumor	13
Assessment of Caregivers and Their Children With Cancer Regarding Information Provided by Healthcare Teams: Advancing Stages Toward the Creation of a Structured Education Program at the National Level	13
Paraneoplastic Ichthyosis Preceding the Diagnosis of Gluteal Rhabdomyosarcoma at Initial Presentation and Relapse	13
A strategic approach to integration of spiritual care into the standards for the psychosocial care of children with cancer and their families	13
A qualitative exploration of parental caregivers’ experience caring for children who have survived medulloblastoma	13
Variant histology of pediatric nodular lymphocyte‐predominant Hodgkin lymphoma with IgD and CD30 expression	13
Diagnosis, monitoring, and management of pyruvate kinase deficiency in children	13
Sarcopenia in long‐term survivors of cancer in childhood and adolescence: A cross‐sectional study of calf muscle mass by peripheral quantitative computed tomography with an examination of the muscle–b	13
Novel ELANE mutation causing severe congenital neutropenia with unpredictable fluctuations in neutrophil counts	13
A proposed algorithm for evaluation and management of pediatric hemophilia patients who present to the emergency department with head trauma	12
Treatment Landscape in Pediatric Immune Thrombocytopenia: Addressing Unmet Needs	12
Epidemiology of clinically unsuspected venous thromboembolism in children with cancer: A population‐based study from Maritimes, Canada	12
Genetic characteristics and treatment outcome in infants with KMT2A germline B‐cell precursor acute lymphoblastic leukemia: Results of MLL‐Baby protocol	12
Unraveling Juvenile Hyaline Fibromatosis: A Case of Novel ANTXR2 Mutations Associated with Subcutaneous Masses and Hydronephrosis	12
Corrigendum	12
SNAP: Supportive non‐invasive ventilation for acute chest syndrome prevention for hospitalized children with sickle cell disease: Perspectives of patients, parents, and the healthcare team	12
Baseline Characteristics of Parents Enrolled in Children's Oncology Group Study ACCL20N1CD: Financial Toxicity During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States	12
Bone marrow hematoidin crystals in a pediatric patient with chondroblastic osteosarcoma	12
Brentuximab vedotin as a single agent in the treatment of a pediatric primary cutaneous CD30⁺ lymphoproliferative disorder: A case report	12
Platelet transfusions in neonates—Unresolved aspects and future directions	12
Parental Acceptance of Human Papillomavirus Vaccination Among Females Treated for Childhood Cancer and/or With Hematopoietic Stem Cell Transplantation: A Cross‐Sectional Study	12
Uniting for Change: The GLOW Initiative and Its Impact on Nodular Lymphocyte‐Predominant Hodgkin Lymphoma	12
Age‐ and sex‐specific rates of gall bladder disease in children with sickle cell disease	12
Incidence and survival for childhood cancer by endorsed non‐stage prognostic indicators in Australia	12
Wilms tumor characteristics, surgical management, outcomes, and chronic kidney disease in children with WAGR syndrome: A report from the International WAGR Syndrome Association survey	12
Image‐defined risk factors in localized thoracic neuroblastoma and ganglioneuroma	12
Abnormal coronary hyperperfusion due to a giant hemangioendothelioma in fetal distress: A case report	12
FANCC and PTCH1 gene loss in congenital infantile rhabdomyosarcoma with spindle cell features	11
Introduction to fertility preservation in pediatric patients with cancer: A report from the Children's Oncology Group	11
Impact of magnetic resonance angiography parameters on stroke prevention therapy in pediatric patients with sickle cell anemia	11
Thalidomide‐associated autoimmune hemolytic anemia	11
Characterization of KMT2A::MATR3 fusion in a patient with acute lymphoblastic leukemia and monitoring of minimal residual disease by nanoplate digital PCR	11
The evidence is mounting: Insurance coverage disruptions lead to worse outcomes among children diagnosed with cancer	11
Survey of the use of traditional and complementary medicine among children with cancer at three hospitals in Cameroon	11
Dyadic coping experiences of parents of children with vascular anomalies	11
Shifting perspectives and transformative change: Parent perspectives of an active music engagement intervention for themselves and their child with cancer	11
Successful hematopoietic stem cell transplantation in MYH9‐related congenital thrombocytopenia	11
Correlation between asparaginase enzyme activity levels and coagulation parameters during childhood acute lymphoblastic leukemia treatment	11
Long‐term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS)	11
Cytarabine dose reduction in patients with low‐risk acute myeloid leukemia: A report from the Children's Oncology Group	11
De novo antiphospholipid antibody syndrome in two infants	11
Good engraftment after reduced intensity targeted busulfan‐based conditioning and matched related donor hematopoietic cell transplantation in hemoglobinopathies	11
Efficacy and safety of azacitidine in pediatric patients with newly diagnosed advanced myelodysplastic syndromes before hematopoietic stem cell transplantation in the AZA‐JMML‐001 trial	11
B‐cell lymphoblastic leukemia in an adolescent with Dravet syndrome	11
Stomatocytes, a whistleblower for future familial cardiovascular events: Unraveling the diagnosis of sitosterolemia in an Indian family	11
Time to diagnosis among young patients with cancer	11
How we approach genetics in the diagnosis and management of vascular anomalies	11
Comprehensive fertility preservation can be offered in a timely manner around gonadotoxic therapy in children and adolescents	11
Surgical aspects and outcomes after nephrectomy for Wilms tumour in sub‐Saharan Africa: A report from Wilms Africa Phase II—CANCaRe Africa	11
Challenge implementing Pediatric Early Warning Systems to improve early identification of clinical deterioration in hospitalized children with cancer: Is it the score?	11
Provision of a personalized survivorship care plan and its impact on cancer‐related health literacy among childhood cancer survivors in Hong Kong	11
Pulmonary hypertension screening in children with sickle cell disease	11
Fusion transcripts as liquid biopsy markers in alveolar rhabdomyosarcoma and synovial sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS)	11
Correction to: Applying the COM‐B model to patient‐reported barriers to medication adherence in pediatric acute lymphoblastic leukemia	11
Allogenic haematopoeitic stem cell transplant as cure for severe transfusion‐dependent non‐dominant hereditary spherocytosis due to homozygous SPTA1 mutation	11
CIC–NUTM1 sarcoma in an 8‐year‐old female patient with a new fusion: A case report	11
Use of milrinone to support therapy‐induced heart failure through hematopoietic stem cell transplantation in a pediatric patient with high‐risk FLT3+ acute myeloid leukemia	10
New therapeutics for children with sickle cell disease: A time for celebration, caution, or both?	10
Spontaneous regression of a greater than 5 cm infant neuroblastoma after a three‐fold volume increase without life‐ or organ‐threatening features	10
Abstracts from the 39^th Annual Meeting of the Histiocyte Society	10
An SRF‐rearranged malignant cellular myoid neoplasm with a novel SRF–MKL2 fusion	10
Behavioral and Electrophysiological Assessment of Central Auditory Processing in Individuals With Sickle Cell Disease	10
Cyclin D2 gene variance and expression level in pediatric acute lymphoblastic leukemia	10
Intraventricular topotecan in the successful treatment of recurrent CNS pleuropulmonary blastoma	10
Cancer does not wait: Safeguarding care for pediatric acute lymphoblastic leukemia patients during the COVID‐19 pandemic in a Mexican hospital	10
Atypical presentations of RECQL4‐related syndromes	10

Programmed cell death protein blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation in an adolescent patient	10
A novel mobile health application to support cancer surveillance needs of patients and families with cancer predisposition syndromes	10
Risk of Metabolic Syndrome and Glucose Homeostasis Among Childhood and Young Adult Acute Lymphoblastic Leukemia Survivors: Part of the ALL‐STAR Study	10
Complete response of metastatic alveolar soft part sarcoma in an adolescent female treated by combined immune checkpoint inhibitors	10
Chemotherapy‐induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care	10
Addition of arm anthropometry to body mass index for age, but not serum albumin, improves the accuracy of the nutritional assessment in severely and moderately malnourished children with cancer	10
Acute exacerbation of graft‐versus‐host disease following SARS‐CoV2 infection after hematopoietic stem cell transplant in two pediatric patients	10
Cognitive predictors of social adjustment in pediatric brain tumor survivors treated with photon versus proton radiation therapy	10
Clinic reported facilitators and barriers to pediatric cancer survivor care delivery among survivorship clinics: A fishbone analysis	10
Recurrent thrombosis with a mispositioned stent after treatment of an adolescent with May–Thurner syndrome	10
Congenital rhabdomyosarcoma: A report from the European paediatric Soft tissue sarcoma Study Group	10
Continuous blood purification successfully treated severe cytokine release syndrome and immune effector cell‐associated neurotoxicity syndrome after chimeric antigen receptor T‐cell therapy: A case re	10
Pediatric Acute B‐Lymphoblastic Leukemia Presenting as Hypereosinophilia With Lung Involvement and Elevated Immunoglobulin E Levels	10
Correction to “Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma”	10
Lack of benefit from premedication for pegylated asparaginase during pediatric acute lymphoblastic leukemia/lymphoma therapy: A side‐by‐side comparison	10
Socioeconomic Factors Associated With Participation in Postmortem Tissue Donation in Pediatric Central Nervous System Tumors	10
Issue Information	10
Familial hemophagocytic lymphohistiocytosis onset as central diabetes insipidus in a child	10
Prevalence of neuropathic pain in adolescents with sickle cell disease: A single‐center experience	10
NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocol	10
Location of death and hospice use in children with cancer varies by type of health insurance	10
Modern surgical strategies in pediatric neuroblastoma: Evolving approaches and treatment principles	10
Contemporary surgical management of pediatric non‐rhabdomyosarcoma soft tissue sarcoma	10
Daratumumab‐induced minimal residual disease negative remission in CD38 (dim)‐positive pediatric acute myeloid leukemia	10
Pediatric refractory immune thrombocytopenia: A systematic review	9
Effects of a Low Versus Moderate–High Intense Exercise Program on Innate Immune Recovery, Fitness, and Quality of Life During Pediatric Allo‐HSCT—The ANIMAL Exploratory Randomized Controlled Trial	9
Prognostic value of chest x‐ray‐ and CT‐defined large mediastinal adenopathy in high‐risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831	9
SARS‐CoV‐2 vaccine acceptability among caregivers of childhood cancer survivors	9
Erratum	9
Clinical Practice Guideline for the Management of Communication and Swallowing in Children Diagnosed With Childhood Brain Tumor or Leukemia	9
Pain mitigation and management strategies for anti‐GD2 infusions: An expert consensus	9
A comprehensive assessment of the prolonged febrile neutropenia evaluation in pediatric oncology patients	9
Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single‐center case series	9
Neuroblastoma with neonatal cardiogenic shock and multiple‐organ failure: A rare association	9
Feasibility of telehealth exercise and nicotinamide riboside supplementation in survivors of childhood cancer at risk for diabetes: A pilot randomized controlled trial	9
Blood counts in children with Down syndrome	9
Combinatorial effects of azacitidine and trametinib on NRAS‐mutated melanoma	9
Intra‐abdominal desmoplastic small round cell tumor: The European pediatric Soft tissue sarcoma Study Group (EpSSG) experience	9
Transatlantic progress in measurement of cognitive outcomes in paediatric oncology trials	9
Coagulopathy and related complications following sclerotherapy of congenital venous malformations	9
Associations between Medicaid enrollment and diagnosis stage and survival among pediatric cancer patients	9
Associations Between Pain Scores and Opioid Doses With Emergency Department Disposition and Return Visit Rates in Children With Sickle Cell Disease	9
The quality and content analysis of YouTube videos about chemotherapy for children	9
Comparison of transfusion reactions in children and adults: A systematic review and meta‐analysis	9
Sirolimus for management of GI bleeding in blue rubber bleb nevus syndrome: A case series	9
Marginal Zone B‐Cell Lymphoma With Marked Plasmacytic Differentiation and Increased Large Cells in a Teenage Male With Serine/Threonine Kinase‐4 Deficiency	9
B‐Lymphoblastic Leukemia With TCF3::PBX1 Fusion Presenting a Mature B‐Cell Phenotype and Lambda Light‐Chain Restriction	9
Contemporary Biology, Management, and Outcomes of Renal Medullary Carcinoma in Children and Adults: A Pediatric Surgical Oncology Research Collaborative Study	9
Comment on: Trends in blood transfusion, hydroxyurea use, and iron overload among children with sickle cell disease enrolled in Medicaid, 2004–2019. Emerging therapeutic options for sickle cell anemia	9
Results of a Randomized Augmented Intensification Phase in Acute Lymphoblastic Leukemia in Children in Argentina: GATLA 2010 ALL IC Trial	9
Spinal Atypical Teratoid/Rhabdoid Tumor with Metastatic Lesions in the Bilateral Acoustic Nerves	9
How we approach lymphedema in the pediatric population	9
Pre‐transplant glomerular hyperfiltration is not a risk factor for increased renal morbidity and mortality in pediatric stem cell transplant patients	9
Treatment of high‐risk Hodgkin lymphoma with a modified Stanford V regimen in the AHOPCA: Substituting chemotherapy agents and hampered outcomes	9
Philadelphia chromosome‐like B‐acute lymphoblastic leukemia and disseminated juvenile xanthogranulomatosis with shared KRAS mutation	9
Pneumatosis intestinalis in the pediatric oncology population: An 11‐year retrospective review at Memorial Sloan Kettering Cancer Center	9
Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high‐risk first relapse B‐cell precursor acute lymphoblastic leukemia	9
Comment on: A Comparative Analysis of Clinical Utility of Cytogenetics and Copy‐Number–Integrated Risk Stratification Scores in a Prospective Cohort of Pediatric B‐Cell Acute Lymphoblastic Leukemia	9
Current approaches to management of bone sarcoma in adolescent and young adult patients	8
Myelodysplastic syndrome in a patient with Barth syndrome (3‐methylglutaconic aciduria type II)	8
A success story of an infantile anaplastic large cell lymphoma: A case report	8
Indications and Outcomes for Tracheostomies in Pediatric Oncology Patients—A Single Center Study	8
Pediatric severe factor XI deficiency: A multicenter study	8
EZH2 is a key component of hepatoblastoma tumor cell growth	8
Development of a blueprint for sibling psychosocial services: A nationwide study	8
The pervasive influence of systems of power on transition readiness for adult care in sickle cell disease: A qualitative study	8
A nomogram model to predict prognosis of patients with hepatoblastoma	8
Neuropsychological, behavioral, and quality‐of‐life outcomes in children and adolescents with sickle cell disease treated with nonmyeloablative matched sibling donor hematopoietic cell transplantation	8
Hyperthyroidism following transplantation and SARS‐CoV‐2 exposure	8
Successful administration of CD19 chimeric antigen receptor T cells in association with severe cyanotic congenital heart disease	8
Circumcision bleeding rates in patients diagnosed with delta‐storage pool deficiency later in life	8
Symptomatic osteonecrosis in children treated for Hodgkin lymphoma: A population‐based study in Sweden, Finland, and Denmark	8
Can virtual care reduce treatment burden in pediatric leukemia? A retrospective cost analysis	8
Systemic Inflammatory Response Post Alemtuzumab and Low‐Dose Total Body Irradiation in Pediatric Patients With Sickle Cell Disease: A Case Series	8
The Global Prevalence of Iron Deficiency in Collegiate Athletes: A Systematic Review and Meta‐Analysis	8
BRAF‐V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first‐line therapy	8
Can you hear me now? Tools for cultivating a culture of respect, value, and appreciation within pediatric hematology, oncology, and cellular therapy	8
A Retrospective Single‐Center Study of Ferric Derisomaltose in Adolescent Patients	8
Excellent response to treatment with hydroxychloroquine in pediatric patients with SLE‐related immune thrombocytopenia	8
Myeloproliferative neoplasm with eosinophilia and PDGFR beta rearrangement in an infant	8
Severe Precapillary Pulmonary Hypertension and Right Ventricular Failure After Hematopoietic Stem Cell Transplantation: Successful Outcomes With Aggressive Upfront Triple Therapy	8
“Per protocol” practice patterns for Children's Oncology Group trials within the radiation oncology community	8
“I was very scared when I found out my son had sickle cell”: Caregiver knowledge and attitudes toward early intervention for young children with sickle cell disease: Implications for policy and practi	8
Prognostic value of hemogram parameters in osteosarcoma: The French OS2006 experience	8
Episodes of acute methotrexate‐related neurotoxicity linked to compromised long‐term neurocognitive function	8
Sacrococcygeal teratoma: Long‐term outcomes. A UK CCLG Surgeons Group Nationwide Study	8
Comment on: Patients with nonmetastatic embryonal rhabdomyosarcoma arising in the biliary tract should be treated on low‐risk clinical trials	8
	8
Treatment of newly diagnosed severe aplastic anemia in children: Evidence‐based recommendations	8
Communication, academic and social outcomes of childhood cancer survivors with hearing loss: A systematic review	8
Exploring height outcomes with adjuvant aromatase inhibition in growth hormone–deficient male survivors of childhood cancer	8
Face validity of the Kids’ ITP Tools (KIT) in the era of thrombopoietin receptor agonists	8
Pediatric Hematology Oncology Building Education and Training Success (PHO BEATS): A Conference to Raise Awareness and Interest for Residents and Medical Students	8
Diagnosis and management of isolated neutropenia: A survey of pediatric hematologist oncologists	8
Acute Liver Failure in a 17‐Year‐Old Boy Caused by a Blastic Plasmacytoid Dendritic Cell Neoplasm With a Novel MYB Rearrangement	8